A Study of ES104 in Patients With Metastatic Colorectal Cancer

ABSTRACT: The purpose of this open-label, Multicenter Phase I/II study is to evaluate the safety, tolerability, preliminary anti-tumor efficay, pharmacokinetics, anti-drug antibodies and biomarkers of ES104 in patients with unresectable locally advanced or metastatic colorectal cancer who have failed systemic therapies.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2399114 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR